Anggot, Rogelio L.
HRN: 18-22-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2026
CEFTRIAXONE 1G (VIAL)
06/07/2026
06/14/2026
IV
2g
OD
Presumptive TB
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines